FDA Cleared ≠ FDA Validated - Summary - MDSpire
Commentary & Perspectives
From the Journals

FDA Cleared ≠ FDA Validated

Most AI medical devices reach the market without independent evidence of safety or effectiveness.

Share

Over 1,400 AI medical devices are currently available, yet most lack rigorous premarket studies, which raises concerns about their effectiveness and safety. A significant gap exists between physician expectations for randomized clinical trials before device use and reality. Most devices enter the market via the 510(k) pathway, requiring only substantial equivalence to existing devices without independent safety demonstrations. This situation highlights the need for better surveillance systems and transparency regarding AI tools within clinical practices as proposed changes could hinder oversight.

Original Source(s)

FDA Cleared ≠ FDA Validated

  • by Kerri Miller

  • May 4, 2026

Related Content

Pharma Supply Chains in the Crossfire

How tariff uncertainty and geopolitical tensions are reshaping pharmaceutical logistics

  • May 5, 2026

  • 8 min
AI Outperforms MDs on Reasoning Tasks

Across six experiments—including a blinded, real-world ER evaluation—an OpenAI large language model outperformed physician baselines on multiple clinical reasoning tasks, though not on key safety endpoints such as cannot-miss diagnoses

Food Fight Brewing in Hospitals

New federal diet push collides with clinical realities, as doctors weigh patient needs against policy signals.